Chelsea Therapeutics International Ltd. (NASDAQ:CHTP)

CAPS Rating: 2 out of 5

A development stage pharmaceutical company that seeks to acquire and develop innovative products for the treatment of a variety of human diseases.

Recs

0
Player Avatar awosha1 (64.01) Submitted: 12/17/2012 8:39:16 PM : Outperform Start Price: $0.89 CHTP Score: +593.21

A marginal drug with only one marginal competitor in the space stillhas lots of hope.

Featured Broker Partners


Advertisement